v3.19.1
Condensed Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 11,394,244 $ 3,869,043
Prepaid research and development 379,670 505,960
Prepaid expenses and other current assets 279,422 317,547
Total Current Assets 12,053,336 4,692,550
Intangible assets - net 6,593 6,735
Total Other Assets 6,593 6,735
Total Assets 12,059,929 4,699,285
Current Liabilities:    
Accrued research and development expenses  
Accounts payable and accrued expenses 329,192 257,974
Total Current Liabilities 329,192 257,974
Commitments and contingencies  
Stockholders' Equity    
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at March 31, 2019 and December 31, 2018
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 10,168,826 and 6,862,499 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively 10,169 6,863
Additional paid in capital 26,438,589 16,469,818
Accumulated deficit (14,718,021) (12,035,370)
Total Stockholders' Equity 11,730,737 4,441,311
Total Liabilities and Stockholders' Equity $ 12,059,929 $ 4,699,285

Source